ADHD medications- Methylphenidate and its side and adverse effects

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorLevy, Toot Viktoria
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.date.accessioned2020-02-24T10:53:28Z
dc.date.available2020-02-24T10:53:28Z
dc.date.created2019
dc.description.abstractSeveral types and subtypes of medications are available to treat ADHD (attention deficit hyperactive disorder). The most prevalent prescribed treatment is with CNS stimulatory drugs (stimulants) which include methylphenidate (MPH) and amphetamines. Although not fully understood, MPH unique mechanism is believed to contribute to its high effectiveness in treating ADHD. However, initiating treatment and side effects which vary in prevalence and severity. The most common side effects include insomnia, nausea, vomiting, anorexia and anxiety. Furthermore, MPH has an abuse potential which may lead to more severe complications. Due to MPH shortcomings and risks, it should only be used when indicated and prescribed and preferably monitored by a physician.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent38hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/281205
dc.language.isoenhu_HU
dc.subjectADHD medicationshu_HU
dc.subjectMethylphenidate side effectshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleADHD medications- Methylphenidate and its side and adverse effectshu_HU
Fájlok